Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Jul 1;30(7):781-783.
doi: 10.1097/GME.0000000000002190. Epub 2023 Jun 13.

Testosterone use for hypoactive sexual desire disorder in postmenopausal women

Sharon J Parish  1 , Juliana M Kling  2
Affiliations
Meta-Analysis

Testosterone use for hypoactive sexual desire disorder in postmenopausal women

Sharon J Parish et al. Menopause. .

Abstract

Testosterone is an important evidence-based therapy for hypoactive sexual desire disorder (HSDD) in postmenopausal women. Clinical practice guidelines based on the most comprehensive meta-analysis of benefits and risks of testosterone therapy to date state that the sole evidence-based indication for testosterone therapy is HSDD in postmenopausal women. The guidelines also provide recommendations regarding identification of patients, dosing, monitoring, and follow-up. This Practice Pearl will discuss evidence-based testosterone therapy for management of HSDD in postmenopausal women.

PubMed Disclaimer

References

    1. Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol 2008;112:970–978. doi: 10.1097/AOG.0b013e3181898cdb - DOI
    1. Parish SJ, Goldstein AT, Goldstein SW, et al. Toward a more evidence-based nosology and nomenclature for female sexual dysfunctions—part II. J Sex Med 2016;13:1888–1906. doi: 10.1016/j.jsxm.2016.09.020 - DOI
    1. Clayton AH, Goldstein I, Kim NN, et al. The International Society for the Study of Women’s Sexual Health process of care for management of hypoactive sexual desire disorder in women. Mayo Clin Proc 2018;4:467–487. doi: 10.1016/j.mayocp.2017.11.002 - DOI
    1. Parish SJ, Simon JA, Davis SR, et al. International Society for the Study of Women’s Sexual Health clinical practice guideline for the use of systemic testosterone for hypoactive sexual desire disorder in women. J Sex Med 2021;18:849–867. doi: 10.1016/j.jsxm.2020.10.009 - DOI
    1. Davis SR, Moreau M, Kroll R, et al; APHRODITE Team Study. Testosterone for low libido in menopausal women not taking estrogen therapy. N Engl J Med 2008;359:2005–2017. doi: 10.1056/NEJMoa0707302 - DOI

Publication types